ID   HFWT
AC   CVCL_8691
DR   CLO; CLO_0050899
DR   BioSample; SAMN03472268
DR   RCB; RCB0665
DR   Wikidata; Q54883308
RX   PubMed=1850701;
RX   PubMed=11927014;
CC   Population: Japanese.
CC   Doubling time: 48 hours (Note=At 5th passage), 41 hours (Note=At 20th passage), 40 hours (Note=At 50th passage) (PubMed=1850701).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=1850701; DOI=10.1016/S0232-1513(11)80040-X;
RA   Ishiwata I., Ono I., Ishiwata C., Soma M., Nakaguchi T., Ohara K.,
RA   Hirano M., Ishikawa H.;
RT   "Carcinoembryonic proteins produced by Wilms' tumor cells in vitro and
RT   in vivo.";
RL   Exp. Pathol. 41:1-9(1991).
//
RX   PubMed=11927014; DOI=10.1111/j.1349-7006.2002.tb02174.x;
RA   Harada H., Saijo K., Watanabe S., Tsuboi K., Nose T., Ishiwata I.,
RA   Ohno T.;
RT   "Selective expansion of human natural killer cells from peripheral
RT   blood mononuclear cells by the cell line, HFWT.";
RL   Jpn. J. Cancer Res. 93:313-319(2002).
//